(Q43507851)

24 November 2017

title

Nonalcoholic fatty liver disease in Asia: a story of growth (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

24 November 2017

1 reference

1 reference

1 reference

Vincent Wai-Sun Wong

1

1 reference

24 November 2017

publication date

1 January 2013

1 reference

Journal of Gastroenterology and Hepatology

24 November 2017

published in

1 reference

24 November 2017

volume

28

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

18-23

1 reference

Nonalcoholic fatty liver disease: from steatosis to cirrhosis

24 November 2017

cites work

1 reference

Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.

21 January 2018

1 reference

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people

21 January 2018

1 reference

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

21 January 2018

1 reference

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

21 January 2018

1 reference

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

21 January 2018

1 reference

Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.

21 January 2018

1 reference

21 January 2018

Transient elastography

1 reference

Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases.

21 January 2018

1 reference

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

21 January 2018

1 reference

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.

21 January 2018

1 reference

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus

21 January 2018

1 reference

Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

21 January 2018

1 reference

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.

21 January 2018

1 reference

How should we manage patients with non-alcoholic fatty liver disease in 2007?

21 January 2018

1 reference

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

21 January 2018

1 reference

Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors

21 January 2018

1 reference

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis.

21 January 2018

1 reference

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JGH.12011

1 reference

24 November 2017

1 reference